American Pharmacy News
  • People
  • Innovation
  • Regulatory
  • Industry
  • Federal Issues
  • State Issues
  • Directory
  • People
  • Innovation
  • Regulatory
  • Industry
  • Federal Issues
  • State Issues
  • Directory
  • Home
  • »
  • Stories
  • »
  • American Pharmacy News Reports

Federal Trade Commission files civil action suit against Shire subsidiary

American Pharmacy News Reports | Feb 25, 2017
The U.S. Federal Trade Commission has filed a civil action suit against a subsidiary of Shire.

The U.S. Federal Trade Commission has filed a civil action suit against a subsidiary of Shire, PLC, as part of a citizen petition submission regarding antibiotic Vancocin. Read More »

AbbVie submits New Drug Application for Hepatitis C treatment

American Pharmacy News Reports | Feb 25, 2017
These studies considered a pool of over 2,300 patients throughout 27 countries over all of the major HCV genotypes.

The U.S. Food and Drug Association is reviewing AbbieVie's New Drug Application (NDA) for a new treatment of Hepatitis C virus.  Read More »

FDA approves deflazacort for muscular dystrophy patients

American Pharmacy News Reports | Feb 25, 2017
Marathon plans to release the drug this year under the brand name Emflaza.

The U.S. Food and Drug Administration has approved deflazacort, a new treatment for Duchenne muscular dystrophy in patients 5 years and older. Read More »

Allergan launches campaign against blindness

American Pharmacy News Reports | Feb 23, 2017
Allergan is launching See America to stress the importance of eye health.

Global pharmaceutical leader Allergan is launch a new campaign to bring awareness to blindness, and commit to fighting preventable blindness in the United States in its new See America initiative. Read More »

Teva promotes Peterburg to interim president and CEO

American Pharmacy News Reports | Feb 23, 2017
Yitzhak Peterburg's promotion comes after Erez Vigodman stepped down.

Teva Pharmaceutical Industries' chairman Yitzhak Peterburg has been appointed interim president and chief executive officer. Read More »

HealthQx attains Prometheus Analytics certification

American Pharmacy News Reports | Feb 23, 2017
The episodes cover topics of behavioral health and oncology.

McKesson Health Solutions, a company that specializes in helping patients with medical payments, recently announced its new analytics system HealthQx received certification in the Prometheus Analytics model. Read More »

Competition Act tabled by House committee

American Pharmacy News Reports | Feb 23, 2017
The act seeks to remove barriers regarding competition of generic drugs.

The Lower Drug Costs through Competition Act created by the House Energy and Commerce Committee was taken off the committee’s fast track on Feb. 3 Read More »

Medac passes Service Organization Control 2 certification

American Pharmacy News Reports | Feb 22, 2017
The SOC 2 Type 2 process ensures that Medac is cyber secure.

Medical business management service provider Medac Inc. has completed a Service Organization Control 2 certification. Read More »

GSK launches Flonase ahead of allergy season

American Pharmacy News Reports | Feb 22, 2017
GSK Consumer Healthcare has launched Flonase Allergy Relief.

GSK Consumer Healthcare has launched Flonase Allergy Relief for the treatment of seasonal allergies. Read More »

New data shows Cladribine reduces brain atrophy in patients with MS

American Pharmacy News Reports | Feb 22, 2017
The data was gathered on an EDSS scale, a measure that quantifies disabilities in patients with MS.

Newly released data published in the Multiple Sclerosis Journal shows Cladribine tablets significantly reduce brain atrophy in patients suffering with multiple sclerosis. Read More »

Mylan to host Investor Day

American Pharmacy News Reports | Feb 22, 2017
CEO Heather Bresch and other senior leaders will present on the company’s financial guidance.

Global pharmaceutical maker Mylan will host Investor Day on March 1 in New York City. Read More »

Amgen applies to broaden use of Blincyto

American Pharmacy News Reports | Feb 21, 2017
Blincyto was granted a priority review designation by the FDA.

Biotech company Amgen submitted an application to the U.S. Food and Drug Administration for Blincyto, a drug used in the treatment of lymphoblastic leukemia, to broaden its uses and treatments. Read More »

CDC works in partnership to help Native Americans control diabetes

American Pharmacy News Reports | Feb 21, 2017
The CDC recently reported that community health approaches result in improved diabetes outcomes.

The Missoula Urban Indian Health Center is participating in offering education, care coordination and patient-navigator services to more than 30 Indian tribes.  Read More »

VA to expand pharmacists' roles in health care management

American Pharmacy News Reports | Feb 21, 2017
There are nearly 3 million rural veterans enrolled in VA health care programs.

The Department of Veterans Affairs is looking to expand pharmacists’ roles as health care providers for veterans living in rural communities.  Read More »

CDC offers flu-prevention tips

American Pharmacy News Reports | Feb 21, 2017
The CDC reminds the nation that the flu vaccine is the best defense against contracting the disease.

The Centers for Disease Control and Prevention has releases detailed information on the risks that flu season presents.  Read More »

Legislation allows Medicare to pay pharmacists for additional services

American Pharmacy News Reports | Feb 20, 2017
The bill is supported by the Patient Access to Pharmacists’ Care Coalition.

Recently passed legislation now allows Medicare to pay pharmacists for services provided to beneficiaries in underserved communities. Read More »

Eli Lilly gets European marketing rights for Olumiant

American Pharmacy News Reports | Feb 20, 2017
The European Commission’s approval of Olumiant is an exciting milestone for the rheumatoid arthritis community.

The European Commission has granted Eli Lilly & Co. marketing rights for Olumiant, a drug used to treat patients suffering with severe rheumatoid arthritis. Read More »

Cumberland Pharmaceuticals reports favoraby on Caldolor injection

American Pharmacy News Reports | Feb 20, 2017
Caldolor has been approved by the FDA for use within the pediatric medical realms.

Cumberland Pharmaceuticals Inc.'s recent clinical study showed its Caldolor Injection (ibuprofen) to be a safe and effective source of fever reduction in hospitalized pediatric use. Read More »

AbbVie to present at Cowen and Co. Health Care Conference

American Pharmacy News Reports | Feb 20, 2017
For those unable to log on at the time of the conference, an archived copy of the recording will be available.

AbbVie, a global biopharmaceutical company focused on research, will take part in the upcoming Cowen and Company 37th Annual Health Care Conference.  Read More »

Conference to highlight patient accessibility, co-pays

American Pharmacy News Reports | Feb 18, 2017
Discussions concerning reimbursement of expensive therapeutics will take place.

CBI's Formulary, Co-Pay and Access Summit will convene April 11-12 to address patient affordability barriers and more.  Read More »

  • «
  • 1
  • 2
  • ...
  • 57
  • 58
  • 59 (current)
  • 60
  • 61
  • ...
  • 168
  • 169
  • »
Trending

Scott Newman, Chairman, Pharmacists United for Truth and Transparency

Pharmacists United for Truth and Transparency: PBMs are the ‘primary driver of high drug prices in the U.S.’

Dr. Gerard Acloque, Doctor for Florida Concierge Medicine & Wellness

Doctor on Eli Lilly compounding pharmacy lawsuit: 'We are now left with very little options outside the branded medications'

Sazan Sylejmani, Owner & Pharmacy Manager of Westmont Pharmacy

Monty's Home Medical highlights benefits of tailored compounded medications

Craig Brockie, Founder & CEO of Ultimate Health Solutions

Ultimate Health Solutions founder on Patients First: 'Our healthcare system doesn't reward health'

 Jeff Harrell Board President

NCPA comments on Trump's executive order concerning drug pricing

Copyright © 2025 American Pharmacy News. All Rights Reserved.

  • About
  • Contact
  • Privacy Policy
  • Terms of Service

Alerts Sign-up